The world’s top 2% of most important scientists across all fields have been updated in a new list issued by Stanford University (1). Dr. Teodor Parella, head of the SeRMN-UAB, appears in this Stanford list that includes 3030 spanish researchers from different disciplines, around 300 spanish chemists and 81 researchers from the Universitat Autònoma de Barcelona.
Some of our recent research work was presented at the European NMR meeting Euromar 2021 that was going to take place at Portoroz (Slovenia), but which was finally virtual from the 5th to the 8th of July 2021.
To date, the enantiospecific analysis of mixtures necessarily requires prior separation of the individual components. The simultaneous enantiospecific detection of multiple chiral molecules in a mixture represents a major challenge, which would lead to a significantly better understanding of the underlying biological processes; e.g. via enantiospecifically analyzing metabolites in their native environment. Here, we report on the first in situ enantiospecific detection of a thirty-nine-component mixture. As a proof of concept, eighteen essential amino acids (AAs) at physiological concentrations were simultaneously enantiospecifically detected using NMR spectroscopy and a chiral solvating agent. This work represents a first step towards the simultaneous multicomponent enantiospecific analysis of complex mixtures, a capability that will have substantial impact on metabolism studies, metabolic phenotyping, chemical reaction monitoring, and many other fields where complex mixtures containing chiral molecules require efficient characterization.
L. T. Kuhn, K. Motiram-Corral, T. J. Athersuch, T. Parella, M. Pérez-Trujillo, Angew. Chem. Int. Ed.59 (2020) 23615.
Some of the SeRMN staff has presented our recent research work at the biannual Spanish and IberAmerican NMR meeting, 10th GERMN biennial /9th IberAmerican/7th Iberian NMR Meeting. This year it was a virtual meeting taking place from 26 to 29 April 2021.
Pau Nolis presented an oral communication entitled “Reducing experimental time using Multiple Fid Acquisition“. P. Nolis, K. Motiram-Corral, M. Pérez-Trujillo, T. Parella.
Speeding-up NMR molecular analysis is an important research field which has been continuously advancing since NMR early days. The relevant benefits are clear and evident: i) reduce analysis time per sample => reduce analysis cost; ii) gain spectrometer time to analyze new samples => improve spectrometer efficiency. Multiple FID Acquisition (MFA) strategy consists in the design of NMR pulse sequence experiments accommodating N acquisition windows, each registering different relevant structural information. This strategy is faster than perform a traditional sequential acquisition of N separated experiments. Several design strategies and practical experiments will be shown and discussed.
Míriam Pérez-Trujillo presented an oral communication entitled “Simultaneous Enantiospecific Detection of Multiple Metabolites in Mixtures using NMR Spectroscopy“. L. T. Kuhn, K. Motiram-Corral, T. J. Athersuch, T. Parella, M. Pérez-Trujillo.
Chirality plays a fundamental role in nature, but its detection and quantification still face many limitations. To date, the enantiospecific analysis of mixtures necessarily requires prior separation of the individual components. The simultaneous enantiospecific detection of multiple chiral molecules in a mixture represents a major challenge, which would lead to a significantly better understanding of the underlying biological processes; e.g. via enantiospecifically analyzing metabolites in their native environment. Here, we report on the first in situ enantiospecific detection of a thirty-ninecomponent mixture. As a proof of concept, eighteen essential amino acids (AAs) at physiological concentrations were simultaneously enantiospecifically detected using NMR spectroscopy and a chiral solvating agent. This work represents a first step towards the simultaneous multicomponent enantiospecific analysis of complex mixtures, a capability that will have substantial impact on metabolism studies, metabolic phenotyping, chemical reaction monitoring, and many other fields where complex mixtures containing chiral molecules require efficient characterization.
Workshop limited to 4 participants (first come, first served)
Contact person:
Silvia Lope-Piedrafita, PhD ()
This course combines a comprehensive series of lectures on the technology of Magnetic resonance spectroscopy and imaging (MRS/MRI) with hands-on laboratory sessions to provide practical demonstrations of key concepts and procedures for preclinical studies.
Whether you are considering MRI as a research tool in your lab or just would like to learn more about MRI, this workshop addresses practical aspects of experimental MRI with laboratory animals and provide valuable hands-on experience on a 7 Tesla Bruker BioSpec spectrometer.
To improve the obsolescence of the oldest equipments, the following new NMR spectrometers have been installed/updated at the SeRMN-UAB Facility in May 2021:
A new AVANCE NEO console for the existing 500 MHz NMR spectrometer, equipped with an automated ATMA accessory and a compatible cryoplatform for the current TCI cryoprobe.
A New 400 MHz NMR spectrometer including a ultrashielded ASCEND magnet, automated SAMPLE-CASE sample changer, high-resolution liquid (iProbe) and solid-state (CP-MAS 4.0mm) NMR probes, and a BCU-II unit for automated sample refrigeration until 233K.
3. A New 300 MHz NMR spectrometer including a Nanobay AVANCE nanoNEO console, ultra shielded ASCEND magnet and a BBFO probe head.
4. A cooled SAMPLE-CASE sample changer and a BCU-II unit for automated sample refrigeration until 233K for the existing 600MHz NMR spectrometer
More info about the equipments and accesories can be found at the Bruker WWW site.
The purchase of these equipments has been co-financed by the Ministry of Science, Innovation, and Universities to the 2019 infrastructure call (project EQC2019-005396-P) co-financed by the European Fund for Economic and Regional Development (FEDER) through the plurirregional operating program of Spain (POPE) period 2014-2020.
From 22-6-2020, all authorized SeRMN users can make use of the self-service mode in the 250auto, 360MHz and 400MHz spectrometers, exclusively from 9AM to 5PM, using the booking program (https://sermn.uab.cat/reserves/). The experiment request service is also active for all those samples that are not recorded in self-service mode:
At the moment, the 250robot spectrometer is reserved exclusively for this type of work.
It is very important that the following mandatory rules are respectedt 1. Self-service exclusively from 9AM to 5PM. SeRMN access is not allowed outside of this time slot as there will be no SeRMN staff. 2. Only 1 person per machine is allowed. Always respect two meters of distance separation between people. 3. It is necessary to follow the established protocols of hygiene and safety at a personal level (mask, hand disinfection …) 4. Before and, above all, after using the keyboard and other tools to carry out the experiments (spinner, calibrator …) it is necessary to disinfect them with the hygiene material that you will find available.
Any questions or clarifications, you can contact the staff of the SeRMN who will be present from 9AM to 5PM or through the address .
Després de més de dos mesos d’obligat tancament, el SeRMN reobrirà les seves instal.lacions a partir del proper dilluns dia 25 de Maig. Ja que s’han de mantenir certes precaucions de seguretat i higiene, començarem amb un funcionament limitat, provisional i progressiu a mida que es vagi normalitzant la situació del COVID19. Les normes bàsiques de funcionament són:
1. No hi ha autoservei. No cal fer reserva en el nostre sistema de reserves com es fa habitualment. Les mostres seran analitzades exclusivament pel personal del SeRMN.
2. Prèviament, cal fer una sol.licitud de prestació de servei per a cada mostra a través dels formularis de la nostra plana web:
3. Pels usuaris que treballin a l’edifici de les Facultats de Ciències i Biociències, cal portar la mostra presencialment al SeRMN en horari de matí (9AM-1PM). És important que la mostra estigui ben etiquetada i prèviament desinfectada. L’accés al SeRMN està restringit. Just a l’entrada del SeRMN hi haurà una taula de recepció per desinfectar/deixar/recuperar les mostres (veure https://sct.uab.cat/sermn/sample_delivery_provisional).
4. Degut a l’accés restringit que hi ha a l’edifici de les Facultats de Ciències i Biociències, recomanen als usuaris externs sense autorització d’accés a l’edifici (altres facultats de la UAB, instituts i empreses del PRUAB, i instituts i empreses externes al PRUAB) que es posin en contacte amb el personal del SeRMN per email o per telèfon (93 581 3785 o al 93 581 2291) per concretar el lliurament/recollida de mostres.
Per qualsevol dubte o qüestió, podeu contactar-nos a través del nostre mail institucional () o en els nostres correus personals.
————————————————————————————————————————–
After more than two months of forced closure, the SeRMN will reopen its facilities from next Monday, May 25. Since certain safety and hygiene precautions must be maintained, we will start with a limited, provisional and progressive operation as the COVID-19 situation normalizes. The basic rules of operation are:
1-. There is no self-service. There is no need to make a reservation in our booking system as usual. Samples will be analyzed exclusively by the SeRMN staff.
2-. Previously, a request for service for each sample through the forms on our website is required:
3.- For users working in the building of the Faculties of Sciences and Biosciences, the sample must be brought in person at the SeRMN in the morning (9 AM-1PM). It is important that the sample is well labeled and previously disinfected. The access to the SeRMN lab is restricted. Right at the entrance of the SeRMN there will be a reception table where you must disinfect / leave / recover your samples (see https://sct.uab.cat/sermn/sample_delivery_provisional).
4. Due to the restricted access to the building of the Faculties of Sciences and Biosciences, we strongly recommend to external users without authorization access to the building (other faculties of the UAB, institutes and companies of the PRUAB, and institutes and companies external to the PRUAB) that contact with the staff of the SeRMN by email or telephone (93 581 3785 or 93 581 2291) to specify the delivery of samples.
For any questions or concerns, you can contact us via our institutional email () or in our personal emails.
Progression of Alzheimer’s disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy by Güell-Bosch J, Lope-Piedrafita S, Esquerda-Canals G, Montoliu-Gaya L, and Villegas S. NMR in Biomedicine 33(5):e4263; DOI: 10.1002/nbm.4263.
Alzheimer’s disease (AD) is an incurable disease that affects most of the 47 million people estimated as living with dementia worldwide. The main histopathological hallmarks of AD are extracellular β-amyloid (Aβ) plaques and intracellular neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein. In recent years, Aβ-immunotherapy has been revealed as a potential tool in AD treatment. One strategy consists of using single-chain variable fragments (scFvs), which avoids the fragment crystallizable (Fc) effects that are supposed to trigger a microglial response, leading to microhemorrhages and vasogenic edemas, as evidenced in clinical trials with bapineuzumab. The scFv-h3D6 generated by our research group derives from this monoclonal antibody, which targets the N-terminal of the Aβ peptide and recognizes monomers, oligomers and fibrils.
In this study, 3xTg-AD mice were intraperitoneally and monthly treated with 100 μg of scFv-h3D6 (a dose of ~3.3 mg/kg) or PBS, from 5 to 12 months of age (-mo), the age at which the mice were sacrificed and samples collected for histological and biochemical analyses. During treatments, four monitoring sessions using magnetic resonance imaging and spectroscopy (MRI/MRS) were performed at 5, 7, 9, and 12 months of age. MRI/MRS techniques allow, in a non-invasive manner, to draw an in vivo picture of concrete aspects of the pathology and to monitor its development across time. Compared with the genetic background, 3xTg-AD mice presented a smaller volume in almost all cerebral regions and ages examined, an increase in both the intra and extracellular Aβ1-42 at 12-mo, and an inflammation process at this age, in both the hippocampus (IL-6 and mIns) and cortex (IL-6). In addition, treatment with scFv-h3D6 partially recovered the values in brain volume, and Aβ, IL-6, and mIns concentrations, among others, encouraging further studies with this antibody fragment.
Due to the alarm status by the Covid-19 the UAB’s Nuclear Magnetic Resonance Service will be temporally closed. For any questions you can contact us by email at the institutional address